Ligand validation:6F0U

PLC: DIUNDECYL PHOSPHATIDYL CHOLINE

PLC is a Ligand Of Interest in 6F0U designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6F0U_PLC_D_401	5%	96%	0.32	0.806	0.12	0.22	-	-	3	0	57%	0.5714
6F0U_PLC_E_403	3%	96%	0.354	0.789	0.14	0.23	-	-	1	0	57%	0.5714
6F0U_PLC_D_404	2%	96%	0.422	0.77	0.14	0.21	-	-	1	0	57%	0.5714
6F0U_PLC_C_402	2%	68%	0.361	0.638	0.42	0.8	-	2	1	0	81%	0.8095
6F0U_PLC_A_403	1%	96%	0.428	0.703	0.16	0.19	-	-	1	0	57%	0.5714
6F0U_PLC_B_403	1%	95%	0.44	0.702	0.18	0.23	-	-	3	0	57%	0.5714
6F0U_PLC_A_402	1%	68%	0.422	0.547	0.42	0.81	-	2	1	0	81%	0.8095
6F0U_PLC_E_402	0%	68%	0.435	0.482	0.45	0.79	-	2	1	0	81%	0.8095
6F0U_PLC_B_402	0%	68%	0.446	0.487	0.43	0.79	-	2	1	0	81%	0.8095
6F0U_PLC_D_403	0%	67%	0.425	0.43	0.45	0.81	-	3	1	0	81%	0.8095
3UUB_PLC_F_320	16%	88%	0.19	0.908	0.45	0.22	-	-	0	0	17%	16.669999999999998
6HZ1_PLC_E_401	12%	95%	0.233	0.842	0.19	0.2	-	-	0	0	57%	0.5714
4QH5_PLC_E_403	10%	47%	0.272	0.806	1.1	0.94	2	2	0	0	81%	0.8095
6HZW_PLC_D_403	9%	11%	0.221	0.742	1.83	2.37	3	9	0	0	81%	0.8095
6HYW_PLC_D_401	8%	68%	0.272	0.783	0.48	0.74	-	1	0	0	81%	0.8095
4DOS_PLC_A_603	64%	52%	0.134	0.933	0.97	0.88	2	-	1	0	100%	0.869
4P00_PLC_A_922	12%	42%	0.283	0.836	1.12	1.12	2	3	1	0	90%	0.9048
4P02_PLC_B_802	10%	82%	0.251	0.892	0.26	0.54	-	-	0	0	26%	0.2619
5EJZ_PLC_B_803	10%	72%	0.261	0.91	0.3	0.77	-	-	1	0	21%	0.2143

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.